Anaemia in kidney disease: harnessing hypoxia responses for therapy

Koury, Mark J., Haase, Volker H.·2015·Nature Reviews Nephrology
DOI 10.1038/nrneph.2015.82

Cited by (315)

Items 301–315 of 315

  1. The single-cell kinetics of hematopoietic stem cell differentiation after transplantation-the steady state and the effect of erythropoietin : the steady state and the effect of erythropoietin
    Almut S. Eisele · 2019 · theses.fr (ABES)
  2. Identification de gènes candidats pour l'anémie de Blackfan-Diamond et caractérisation phénotypique
    Manon Saby · 2019 · theses.fr (ABES)
  3. Plasmodium falciparum provoque des altérations importantes de la différenciation érythroïde
    Aurélie Dumarchey · 2024 · theses.fr (ABES)
  4. Establishment of a Rat Model for Renal Anemia Based on 5/6 Nephrectomized Rats
    Yuko Nakayama, Sachiko Kamikawa, Satohiro Masuda · 2026 · Biological and Pharmaceutical Bulletin
  5. Development and temporal validation of a machine learning risk prediction model for anemia in older adults: A NHANES study of an inflammatory–nutritional–renal profile
    Zhiyuan Niu, Lei Ren, Naibo Hu · 2026 · Research Square
  6. Context-Dependent Prognostic Significance of Total Iron-Binding Capacity by Nutritional and Inflammatory Status in Hemodialysis
    Masahiro Eriguchi, Shunichiro Orihara, Yoshihiro Ônishi, Masaru Matsui, Keisuke Okamoto, Ken‐ichi Samejima, Kazuhiko Tsuruya · 2026 · American Journal of Nephrology
  7. Histone deacetylase inhibition ameliorates kidney injury by restoring fibroblast features to myofibroblasts
    Hirotaka Ishioka, Yuma Iwamura, Yusuke Konta, Koji Sato, Koichiro Kato, Tetsuhiro Tanaka, Taku Nakai, Norio Suzuki · 2026 · Life Sciences
  8. The Heart–Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications
    Aodi Fan, Xinwei Chen, Ke Yang, Xuefang Ma, H T Gao, Binyan Wang, Guanwei Fan, Lan Li · 2026 · Biomolecules
  9. Oxygenaging: A Physiological Framework for Geroscience
    Stefano Donegà, Kenneth W. Fishbein, Paolo B. Dominelli, Allison B. Herman, Rafael de Cabo, Myriam Gorospe, Luigi Ferrucci · 2026 · Aging Cell
  10. The role of hypoxia-inducible factors in myocardial ischaemia–reperfusion injury and cardioprotection
    Cong Luo, Tao Li, Jihoon Tak, Matthew DeBerge, Kuang‐Lei Tsai, Holger K. Eltzschig · 2026 · Nature Reviews Cardiology
  11. KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD). Translated into Russian by K.A. Vishnevskii, V.Yu. Ryasnyanskii and A.Yu. Zemchenkov, edited by K.A. Vishnevskii
    Article Editorial · 2026 · Nephrology and Dialysis
  12. Renal anemia: from erythropoietin deficiency to erythropoietin resistance
    Aojiao Chu, Jinyang Bu, Xinfu Zou, Zheng Zhang, Qin Zheng, Ling SHI, Meihong Luo · 2026 · Frontiers in Pharmacology
  13. Effects of clinically available HIF-PH inhibitors on retinal Vegfa transcription
    Junki Hoshino, Kazuki Irie, Akimitsu Konishi, Hideo Akiyama, Yoji Andrew Minamishima · 2026 · Scientific Reports
  14. BindingDB Entry 50016916: Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
    BindingDB · 2023 · UC San Diego
  15. BindingDB Entry 50014351: Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia.
    BindingDB · 2022 · UC San Diego